Quest Diagnostics Incorporated
DGX
Hisse Senetlerindeki Sıralama
#929
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Hisse Fiyatı
$236.69
Piyasa Değeri
$26.12B
Değişim (1 gün)
0.80%
Değişim (1 yıl)
24.31%
Ülke
US
Ticaret Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Quest Diagnostics Incorporated (DGX) için P/B oranı
October 2026 itibarıyla P/B oranı TTM: 3.42
Quest Diagnostics Incorporated şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 3.42'dir. 2024 yılının sonunda şirketin P/B oranı 2.47 idi.
Quest Diagnostics Incorporated için P/B oranı geçmişi 2000 - 2026 arası
Her yılın sonunda P/B oranı
| Yıl | P/B Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 3.42 | 27.00% |
| 2025 | 2.69 | 8.73% |
| 2024 | 2.47 | 0.90% |
| 2023 | 2.45 | -20.49% |
| 2022 | 3.08 | -8.24% |
| 2021 | 3.36 | 42.05% |
| 2020 | 2.36 | -6.87% |
| 2019 | 2.54 | 16.84% |
| 2018 | 2.17 | -20.81% |
| 2017 | 2.74 | -1.37% |
| 2016 | 2.78 | 27.11% |
| 2015 | 2.19 | -3.26% |
| 2014 | 2.26 | 9.68% |
| 2013 | 2.06 | -7.14% |
| 2012 | 2.22 | -11.03% |
| 2011 | 2.50 | 6.13% |
| 2010 | 2.35 | -16.44% |
| 2009 | 2.81 | 0.56% |
| 2008 | 2.80 | -9.01% |
| 2007 | 3.08 | -11.07% |
| 2006 | 3.46 | -8.05% |
| 2005 | 3.76 | -11.59% |
| 2004 | 4.25 | 34.62% |
| 2003 | 3.16 | 1.84% |
| 2002 | 3.10 | -38.04% |
| 2001 | 5.01 | -18.71% |
| 2000 | 6.16 | 0.00% |
Benzer şirketler veya rakipler için P/B oranı
| Şirket | P/B Oranı | P/B Oranı Farkı | Ülke |
|---|---|---|---|
| 4.7411 | 38.77% |
US
|
|
| 3.0143 | -11.77% |
US
|
|
| 31.051 | 808.88% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 95.06% |
US
|
